Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 156 for “"predictive biomarker"”.

  1. VGF: a novel and predictive biomarker of Parkinson’s disease

    … motor impairments. Identifying reliable biomarkers capable of detecting PD during these early stages remains a major clinical challenge. VGF is a neurosecretory precursor protein that undergoes extensive processing to generate multiple neuronal products (peptides/proteins) with …

    cagliari Repository record for VGF: a novel and predictive biomarker of Parkinson’s disease (opens in a new tab) Embargoed

  2. RNA HELICASE, DP103 AS A PREDICTIVE BIOMARKER FOR DOCETAXEL RESPONSE IN ERa-POSITIVE BREAST CANCER

    … OF DP103 WAS INVESTIGATED FOR ITS ROLE AS A BIOMARKER OF CHEMORESPONSE IN BREAST CANCER. IN A RETROSPECTIVE PHASE II STUDY INVOLVING DOCETAXEL BASED NEOADJUVANT THERAPY, CLINICAL RESPONDERS WERE CHARACTERIZED BY A PROGRESSIVE DECREASE IN DP103 EXPRESSION. THIS DECREASE IN DP103 EXPRESSION WAS …

    nus Repository record for RNA HELICASE, DP103 AS A PREDICTIVE BIOMARKER FOR DOCETAXEL RESPONSE IN ERa-POSITIVE BREAST CANCER (opens in a new tab) Download file for RNA HELICASE, DP103 AS A PREDICTIVE BIOMARKER FOR DOCETAXEL RESPONSE IN ERa-POSITIVE BREAST CANCER (opens in a new tab)

  3. Modeling targeted therapy mechanisms and predictive biomarker discovery using human primary non-small cell lung cancer xenografts

    … patients’ tumour morphology, molecular biomarkers, and responses to targeted therapies. Next, the mechanism underlying an unexpected response to the single-agent EGFR-targeting monoclonal antibody Cetuximab was determined in one of our models with de novo T790M mutation. A third study …

    toronto-retro Repository record for Modeling targeted therapy mechanisms and predictive biomarker discovery using human primary non-small cell lung cancer xenografts (opens in a new tab)

  4. Genomic instability as a predictive biomarker for the application of DNA-damaging therapies in gynecological cancer patients

    [ES] El curso natural de los tumores va acompañado de la acumulación progresiva de alteraciones genómicas, propiciando una cadena de eventos que resultan en inestabilidad genómica (IG). Éste fenómeno, caracterizado por alteraciones en el número de copias, constituye un hallmark genómico con impacto …

    upv Repository record for Genomic instability as a predictive biomarker for the application of DNA-damaging therapies in gynecological cancer patients (opens in a new tab)

  5. Baseline serum albumin as a predictive biomarker for efficacy of Bevacizumab in non small cell lung cancer (NSCLC) patients

    Ο καρκίνος πνεύμονα είναι η κύρια αιτία θανάτου από καρκίνο σε όλες τις ανεπτυγμένες χώρες. Η συνολική 5-ετής επιβίωση των ασθενών είναι μικρότερη του 15%. Η θνητότητα του καρκίνου πνεύμονα είναι μεγαλύτερη από το σύνολο της θνητότητας του καρκινου του μαστού, του προστάτη και του παχέος εντέρου. …

    athens Repository record for Baseline serum albumin as a predictive biomarker for efficacy of Bevacizumab in non small cell lung cancer (NSCLC) patients (opens in a new tab)

  6. Application of whole genome amplification for the investigation of genomic mutations in Hodgkin’s lymphoma AND comparing and contrasting different approaches to identifying predictive biomarker combinations

    … problem. In this study we attempt to design a biomarker tool based on steroid metabolic excretion data containing 32 distinct adrenal derived steroid secretions obtained from 102 ACA patients and 45 ACC patients. Variable selection was performed by forward selection, stepwise selection, and all …

    birmingham Download PDF for Application of whole genome amplification for the investigation of genomic mutations in Hodgkin’s lymphoma AND comparing and contrasting different approaches to identifying predictive biomarker combinations (opens in a new tab)

  7. An adaptive clinical trial design for a sensitive subgroup examined in the multiple sclerosis context

    … In this thesis, generalizations to the Biomarker-Adaptive Threshold Design (BATD) are studied and applied in the multiple sclerosis (MS) context. The BATD was originally developed for survival outcomes for Phase III clinical trials and allows researchers to both study the efficacy of …

    ubc Repository record for An adaptive clinical trial design for a sensitive subgroup examined in the multiple sclerosis context (opens in a new tab) Download PDF for An adaptive clinical trial design for a sensitive subgroup examined in the multiple sclerosis context (opens in a new tab)

  8. Die Signalwegskomponenten LEF-1 und EGFR als Biomarker in der Karzinogenese des kolorektalen Karzinoms

    … to these drugs. For this purpose, suitable predictive biomarkers can be used to assign patients to groups and introduce them to the most suitable therapies. However, not all patients respond to the selected therapy because predictive biomarkers which would allow assigning the best therapy …

    lmu-germany Repository record for Die Signalwegskomponenten LEF-1 und EGFR als Biomarker in der Karzinogenese des kolorektalen Karzinoms (opens in a new tab)

  9. Die Entwicklung eines prädiktiven Biomarker-Score für MET im Magenkarzinom

    Aims: We aimed to develop a putative predictive biomarker score for future hepatocyte growth factor receptor (MET)-targeted therapy of gastric cancer (GC). Methods and results: MET expression and MET ampli- fication were analysed by immunohistochemistry (IHC) and chromogenic in-situ hybridization …

    cau-kiel Repository record for Die Entwicklung eines prädiktiven Biomarker-Score für MET im Magenkarzinom (opens in a new tab)

  10. Epigenomic studies of twins for cancer and cancer risk factors

    … positions (DMPs), three of these showed predictive biomarker potential (near SASH1, COL11A2, and LINC00340). <br/><br/>Early breast cancer specific DNA methylation changes were identified in peripheral blood obtained prior to diagnosis. The DNA methylomes were assessed by two genome-wide …

    kings Repository record for Epigenomic studies of twins for cancer and cancer risk factors (opens in a new tab) Download PDF for Epigenomic studies of twins for cancer and cancer risk factors (opens in a new tab)

  11. Characterization of the Heterogeneous Prognostic Value of Various Mutational Burden Estimates Across the Tumors in the TCGA Cohort

    … somatic mutational data. The usage of TMB as a predictive biomarker of response to immunotherapy has been recently proposed but remains a contentious topic. Most of the previous works on TMB has focused on predicting checkpoint blockade response, but few have properly evaluated TMB as a …

    jhu Repository record for Characterization of the Heterogeneous Prognostic Value of Various Mutational Burden Estimates Across the Tumors in the TCGA Cohort (opens in a new tab)

  12. Development of CDK4/6 Inhibitor Resistant ER-positive HER2-negative Breast Cancer Cell Lines to Elucidate Novel Mechanisms of Resistance

    … due to intrinsic or acquired resistance. Predictive biomarkers to identify patients most likely to respond to initial therapy as well as therapeutic targets to overcome or delay onset of resistance, are needed to improve patient outcomes. To achieve these outcomes will require a better …

    toronto-retro Repository record for Development of CDK4/6 Inhibitor Resistant ER-positive HER2-negative Breast Cancer Cell Lines to Elucidate Novel Mechanisms of Resistance (opens in a new tab)

  13. Development and Evaluation of novel methods for the detection of trypsinogen activation peptide

    … hospital admission. Thus, the availability of a predictive biomarker, working in conjunction with the established classification system, would be advantageous. Several markers such as amylase, lipase and C-reactive protein are used for the diagnosis of AP by hospitals at present. However, it is …

    dcu Download PDF for Development and Evaluation of novel methods for the detection of trypsinogen activation peptide (opens in a new tab)

  14. Clinically relevant MRE11 variants in bladder cancer

    … advantage for either option. Identification of predictive biomarkers could facilitate choice between treatments and potentially improve overall survival rates. MRE11 is a damage signaling protein whose function is crucial for in the DNA damage response. Intriguingly, expression of MRE11 by …

    oxford Repository record for Clinically relevant MRE11 variants in bladder cancer (opens in a new tab)

  15. Digital Scoring of Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer

    … the stromal region, is a valuable prognostic and predictive biomarker in triple-negative breast cancer (TNBC). However, traditional scoring methods are subjective, labor-intensive, and lack standardization. This paper presents a computational pipeline for automated and quantitative evaluation of …

    washington Repository record for Digital Scoring of Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer (opens in a new tab)

  16. Identifying Candidate Biomarkers of Clinical Response to Ustekinumab in Psoriasis

    … (PASI75). Hence, there is a need to identify predictive biomarkers of response to biologics.<br/><br/>Mechanistic biomarkers i.e., associated with the drug’s mechanism of action, are considered more accurate biomarkers. Moreover, their identification in the blood would prove advantageous as …

    kings Repository record for Identifying Candidate Biomarkers of Clinical Response to Ustekinumab in Psoriasis (opens in a new tab) Download PDF for Identifying Candidate Biomarkers of Clinical Response to Ustekinumab in Psoriasis (opens in a new tab)

Page 1 of 8